Emily Zolfaghari

681 citations
22 papers · 326 indexed · h-index 9
Topics
Ocular Oncology and Treatments (12 papers)Ocular Disorders and Treatments (3 papers)Nonmelanoma Skin Cancer Studies (3 papers)

In The Last Decade

Emily Zolfaghari

20 papers receiving 322 citations

Peers

Emily Zolfaghari
Comparison fields: 5 of 71
  • Ophthalmology 150
  • Oncology 70
  • Surgery 63
  • Infectious Diseases 62
  • Radiology, Nuclear Medicine and Imaging 53
Replace José Luis Bueno with:
José Luis Bueno Spain
Guijin Ji Japan
Dan Luo China
Haoting Zhan China
Jyoti Balani United States
P. Bielefeld France
Matheus Vieira France
Dongsheng Zhang China
Griselda Galindo-Rodrı́guez Mexico
Marie Y. Detrait France
Emily Zolfaghari relative to José Luis Bueno Spain José Luis Bueno's profile →
Citations per field
00.5×4.2×
José Luis Bueno · 1×
Citations per year

Countries citing papers authored by Emily Zolfaghari

Since Specialization
Citations

This map shows the geographic impact of Emily Zolfaghari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Zolfaghari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Zolfaghari more than expected).

Fields of papers citing papers by Emily Zolfaghari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Zolfaghari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Zolfaghari. The network helps show where Emily Zolfaghari may publish in the future.

Co-authorship network of co-authors of Emily Zolfaghari

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Zolfaghari. A scholar is included among the top collaborators of Emily Zolfaghari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Zolfaghari. Emily Zolfaghari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 5
5 36
6 18
7 8
8 6
9 4
10 2
11 1
12 43
13 9
14 2
15 4
16 3
17 4
18 41
19 34
20 35

About Emily Zolfaghari

Emily Zolfaghari is a scholar working on Ophthalmology, Emergency Medicine and Oncology, having authored 22 papers that have together received 326 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (12 papers), Ocular Disorders and Treatments (3 papers) and Nonmelanoma Skin Cancer Studies (3 papers). The work is most often cited by research in Ophthalmology (150 citations), Infectious Diseases (62 citations) and Oncology (70 citations). Emily Zolfaghari has collaborated with scholars based in United States, Philippines and Indonesia. Frequent co-authors include Jonathan W. Kim, Jesse L. Berry, Rima Jubran, Sona Shah, Christopher J. Tignanelli, Basil S. Karam, Nicholas E. Ingraham, Anthony Charles, A. Linn Murphree and Sahar Lotfi‐Emran. Their work appears in journals such as PLoS ONE, Ophthalmology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026